Can It Get Worse? I’m certain that most of us were disappointed with the Appellate Department’s decision last week in Prof.

This clinical-stage biotech targeting kidney and metabolic diseases reported a notable insider sale, recent filings show.

An analysis of the June 2026 final rulemaking that updated the federal independent dispute resolution (IDR) process, the ...

The Income Tax Department has clarified several transition-related issues ahead of the implementation of the Income Tax Act, ...

A new lawsuit claims that an AI company partnered with hundreds of gas stations in California to illegally increase fuel ...

Municipalities would be able to bring about a six-month "pause" in considering data center proposals under a bill that passed ...

The Vatican has responded aggressively to a traditionalist society that consecrated bishops without the pope’s consent. The ...

Discover the best AI tools for content creation in 2026. Compare the top 10 platforms for writing, SEO, video, and social ...

None ...

To help BridgeBio ramp up for the launch of three new medicines, plus approved ATTR-CM med Attruby, Sixth Street and HealthCare Royalty have agreed to invest up to $1 billion in the California biotech ...

Legendary music director Ilaiyaraaja is known for litigating filmmakers when they use his compositions in their films without ...

CAUTION: The content presented on this platform is not intended as financial guidance, and we lack the authorization to offer investment advice. Any material found on this website should not be ...